Assignee
H4 ORPHAN PHARMA
FR·2 granted patents·1 pending application·1 citations·filing 2017–2020
Top patents by PatentIndex Score
3 records- 0171US10624884B2H4 agonist molecule for the treatment of idiopathic pulmonary fibrosisH4 ORPHAN PHARMA·Filed 2019·Granted Apr 21, 2020·1 cites·4 claims
- 0246US12465602B2Use of an opioid molecule for treating dry eye and eyes suffering from allergiesH4 ORPHAN PHARMA·Filed 2020·Granted Nov 11, 2025·0 cites·5 claims
- 0343US2019076422A1Use of an h4 agonist molecule for the treatment of idiopathic pulmonary fibrosisH4 ORPHAN PHARMA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when H4 ORPHAN PHARMA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →